B
Boundless Bio Inc
NASDAQ:BOLD
Boundless Bio Inc
NASDAQ:BOLD
Price:
1.16
USD
Market Closed
Market Cap:
$26m
Relative Value
There is not enough data to reliably calculate the relative value of BOLD.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BOLD
Relative Value
Base Case
Not Available
Multiples Across Competitors
BOLD Competitors Multiples
Boundless Bio Inc Competitors
Boundless Bio Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
B
|
Boundless Bio Inc
NASDAQ:BOLD
|
26m USD | 0 | -0.4 | 1.4 | 1.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
412.7B USD | 6.7 | 98.6 | 16.1 | 22.4 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
206.6B USD | 5.6 | 26.8 | 15.3 | 15.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
186.2B USD | 6.3 | 21.9 | 13.6 | 16.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.6B USD | 10.3 | 31.3 | 23.6 | 24.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.1B USD | 5.8 | 18.5 | 14 | 15.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
70B AUD | 3.2 | 35.5 | 11.7 | 14.7 | |
| NL |
|
argenx SE
XBRU:ARGX
|
40B EUR | 11.4 | 36.5 | 39.8 | 40.6 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
